Difelikefalin Impurity 15 represents a structurally related byproduct that arises during difelikefalin synthesis or degradation. Subtle residue changes alter polarity, aggregation tendency, and chromatographic behavior. Researchers use it as a reference standard for method qualification and impurity profiling. Applications include process characterization, stability studies, and structure-property correlation analysis.
CAT No: Z10-101-199
Difelikefalin Impurity 15 is a synthetic peptide derivative that arises as a structurally related byproduct during the manufacture or analysis of difelikefalin, a selective kappa-opioid receptor agonist. As a defined peptide impurity, it serves as a crucial analytical reference standard for quality control and characterization studies in peptide synthesis and pharmaceutical research. Its well-characterized structure and close similarity to the parent molecule make it highly relevant for method development, impurity profiling, and the validation of analytical techniques within the field of peptide-based drug research.
Analytical method development: Difelikefalin Impurity 15 is frequently utilized in the development and optimization of chromatographic and spectrometric methods for the detection and quantification of peptide impurities. Its inclusion in calibration and validation workflows enables researchers to establish method sensitivity, selectivity, and robustness, ensuring accurate separation and identification of structurally similar peptide entities. The use of such impurities as reference materials is essential for the comprehensive validation of high-performance liquid chromatography (HPLC), mass spectrometry (MS), and related bioanalytical platforms.
Impurity profiling in peptide synthesis: In the context of synthetic peptide manufacturing, the presence and quantification of impurities like this one are critical for process optimization and product quality assessment. Monitoring the levels of Difelikefalin Impurity 15 during process development allows chemists to refine synthetic protocols, minimize byproduct formation, and enhance overall yield and purity. Such impurity profiling is fundamental for ensuring batch-to-batch consistency and for meeting stringent quality benchmarks in research-scale peptide production.
Pharmaceutical research and regulatory studies: The availability of well-characterized peptide impurities supports advanced research into the safety and efficacy of peptide-based drug candidates. Difelikefalin Impurity 15 is used in forced degradation studies, stability testing, and impurity fate analyses to understand the behavior of minor components under various storage and processing conditions. These investigations inform risk assessments and help define impurity limits, supporting the generation of robust data packages for regulatory submissions and internal quality assurance.
Structural elucidation and characterization: Reference impurities such as this peptide derivative are invaluable for the structural elucidation of unknown peaks observed during analytical testing. By comparing retention times, mass spectra, and fragmentation patterns, researchers can confidently assign identities to related impurities and degradation products. This capability is essential for comprehensive characterization of peptide drug substances, facilitating the elucidation of impurity profiles and supporting the development of targeted purification strategies.
Peptide-related research tool: Beyond its role in quality control, Difelikefalin Impurity 15 can serve as a valuable tool in peptide research to probe structure-activity relationships and the impact of minor sequence variations on physicochemical properties. By studying its behavior in analytical and preparative systems, scientists gain insights into the influence of specific modifications or side-chain alterations, informing future design and synthesis of peptide analogs with improved stability, solubility, or receptor selectivity. Such investigations contribute to the broader understanding of peptide chemistry and the optimization of peptide therapeutics.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More